Stocks360

LexaGene Holdings Inc. (LXG.V)

Stock analysis · TSXV · Healthcare · Medical - Devices

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
2.26
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

LexaGene Holdings Inc. (LXG.V) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Oct 29, 2020
EPS $-0.03 vs est. $-0.03
Beat by $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About LexaGene Holdings Inc.

LexaGene Holdings Inc. is a biotechnology company focused on developing and commercializing sophisticated systems for pathogen detection. Their flagship product, MiQLab, is an automated platform engineered to transform pathogen identification within diverse markets, including veterinary and human clinical diagnostics, food and water safety, and various other life science applications. This advanced, automated system is deployed directly at the point of sample collection, offering unparalleled ease of use, high sensitivity, and the capacity to detect a wide range of pathogens. Founded in 2007, the company's headquarters are located in Beverly, Massachusetts.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap